Holen Sie sich die Stockscreener-App
4.29
2.39%
0.10
Handel nachbörslich:
4.28
-0.010
-0.23%
Arbutus Biopharma Corp Aktie (ABUS) Neueste Nachrichten
Form 13D/A Arbutus Biopharma Corp For: 5 October By Investing.com - Investing.com UK
At $5 a share, Arbutus Biopharma (ABUS) accepts tendered shares; Roivant retains about 19.5%. - Stock Titan
The share offer capped at $230M has expired. Arbutus (ABUS) announces final results. - Stock Titan
About 23% of Arbutus shares are being bought back for $230 million. - Stock Titan
Arbutus gains on plans to buy back 46M shares in tender offer - TradingView
Arbutus Announces Preliminary Results of Its US$230 Million Modified “Dutch Auction” Tender Offer - GlobeNewswire
Form 4 Arbutus Biopharma Corp For: 23 September By Investing.com - Investing.com Canada
Q32 Bio (Nasdaq:QTTB)Stock Analysis - simplywall.st
Arbutus Biopharma Stock Price Forecast. Should You Buy ABUS? - StockInvest.us
ABUS Stock Price, Quote & Chart - ChartMill
An 8% holder now reports a passive stake in Arbutus Biopharma (ABUS) - Stock Titan
Arbutus Biopharma Corp (ABUS) Peer Comparison – Compare with Others - Value Research
Arbutus Biopharma (ABUS) Edges Up to $5.12, Stuck Between $4.86 Support and $5.38 ResistanceVolatility Term Structure - careplusvn.com
Arbutus Biopharma Corp (ABUS) Key Financial Ratios – Valuation, Profitability & More - valueresearchonline.com
Quantum BioPharma Ltd Peer Comparison – Compare with Others - Value Research
Cronos Group Inc. Common Share (CRON) Peer Comparison – Compare with Others - Value Research
Acasti Pharma Inc. Class AADR Peer Comparison – Compare with Others - Value Research
Arbutus Biopharma Corp (ABUS) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Arbutus Biopharma Launches Modified Dutch Auction Tender Offer to Repurchase Up to US$230 Million of Common Shares - Quiver Quantitative
Arbutus Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share - Yahoo Finance
Arbutus Commences US$230 Million Modified “Dutch - GlobeNewswire
Arbutus Biopharma Launches $230 Million Tender Offer for Common Shares - Yahoo Finance
Arbutus Biopharma Launches Modified Dutch Auction Tender Offer to Repurchase Up to US$230 Million of Common Shares - Quiver Quantitative
Arbutus Biopharma (NASDAQ:ABUS) Capital Strategy Draws Attention - Kalkine Media
Why Is Arbutus Biopharma Stock Gaining Friday? - TradingView
ABUS Stock Pops As Moderna Settlement Transforms Balance Sheet - StocksToTrade
Arbutus Biopharma Announces $230 Million Modified Dutch Auction Tender Offer for Shares - Kalkine Media
Why is Arbutus Biopharma stock surging today? - Investing.com India
Why is Arbutus Biopharma stock surging today? - Investing.com
Why is Arbutus Biopharma stock surging today? By Investing.com - Investing.com UK
Arbutus Biopharma shares jump after unveiling $230 million share buyback plan - Yahoo Finance
ABUS Stock Surges 10% Today — What’s Driving This Super Rally? - Stocktwits
ABUS Stock Surges 10% Today — What’s Driving This Super Rally? - Yahoo Finance
ABUS Looks 90.4% Undervalued on GF Value™ Despite Possible Value Trap - GuruFocus
Arbutus Biopharma stock surges on $230M buyback plan - Investing.com
Arbutus (NASDAQ: ABUS) plans Dutch auction share buyback - Stock Titan
ABUS Looks 90.4% Undervalued on GF Value™ - GuruFocus
Arbutus Biopharma Announces Plans for Up to $230 Million Modified Dutch Auction Tender Offer - Quiver Quantitative
Arbutus Announces Intent to Repurchase Up to US$230 Million - GlobeNewswire
Arbutus Biopharma Corporation announces an Equity Buyback for $230 million worth of its shares. - marketscreener.com
Arbutus Gains on $230m Buyback Using Moderna Settlement Proceeds - Bloomberg.com
ABUS Stock Surges 10% Today — What’s Driving This Super Rally? - TradingView
Moderna, Arbutus Clash On Gov't Venue For Vax IP Claims - Law360
Arbutus Plans $230 Million Share Buyback After Moderna Deal - MyChesCo
Arbutus Biopharma (NASDAQ:ABUS) Cut to Hold at Wall Street Zen - MarketBeat
ABUS|Arbutus Biopharma Corp|Price:4.710|Chg%:+0.130 - TradingKey
Arbutus Biopharma (ABUS) Stock Profit Surge Leaves Durability Questions Open - simplywall.st
Morgan Stanley (ABUS) units report near-9% Arbutus Biopharma stake in 13G/A filing - stocktitan.net
Arbutus Biopharma earnings matched, revenue topped estimates By Investing.com - Investing.com Nigeria
Arbutus Biopharma (NASDAQ:ABUS) Releases Quarterly Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat
5.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):